Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Goodwill: 2009-2025

Historic Goodwill for Prestige Consumer Healthcare (PBH) over the last 15 years, with Sep 2025 value amounting to $528.4 million.

  • Prestige Consumer Healthcare's Goodwill fell 0.15% to $528.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $528.4 million, marking a year-over-year decrease of 0.15%. This contributed to the annual value of $527.4 million for FY2025, which is 0.06% down from last year.
  • Prestige Consumer Healthcare's Goodwill amounted to $528.4 million in Q3 2025, which was up 0.02% from $528.3 million recorded in Q2 2025.
  • Prestige Consumer Healthcare's 5-year Goodwill high stood at $579.0 million for Q1 2022, and its period low was $526.9 million during Q3 2023.
  • Its 3-year average for Goodwill is $527.9 million, with a median of $527.7 million in 2024.
  • In the last 5 years, Prestige Consumer Healthcare's Goodwill climbed by 0.50% in 2021 and then dropped by 8.88% in 2023.
  • Prestige Consumer Healthcare's Goodwill (Quarterly) stood at $578.9 million in 2021, then decreased by 0.40% to $576.6 million in 2022, then dropped by 8.45% to $527.9 million in 2023, then dropped by 0.12% to $527.2 million in 2024, then declined by 0.15% to $528.4 million in 2025.
  • Its Goodwill was $528.4 million in Q3 2025, compared to $528.3 million in Q2 2025 and $527.4 million in Q1 2025.